Two Bay State biotechs are in a deal to combine their strengths to deliver individualized treatment for cancer patients.
Pittsfield-based Nuclea, a biotech company specializing in diagnostic tests for cancer patients, has reached an agreement to buy Cambridge biomarker-test maker WILEX Inc., formerly a subsidiary of Munich's WILEX AG.
The acquisition will allow Nuclea to get its tests in hospitals, where they can be used to recommend an effective treatment for some tumors, sooner.
"It drives us into the marketplace much quicker than we would have been able to do on our own," said Patrick Muraca, president and CEO of Nuclea.
"This will help get these tests into patients' hands and into the market very quickly."
The tests use genetic and protein testing to recommend a course of treatment that will be the most effective for tumors — including renal cell carcinoma, prostate cancer and breast cancer.
"It helps determine what therapy is appropriate for a specific patient," Muraca said.
Nuclea will continue to use WILEX's manufacturing facility in Cambridge, which will allow the company to accelerate its timeline by roughly six months, Muraca said.
The acquisition is an opportunity to "strengthen Nuclea's portfolio and continue to move into the commercial realm," he said.
The company will make use of the Cambridge location, giving the company a much-needed footprint near key partners, including Dana-Farber Cancer Institute and the Joslin Diabetes Center.
"It positions us very well with those institutions," Muraca said.
Nuclea will absorb all 11 of WILEX's jobs and will fill seven more positions at the Cambridge location, Muraca said.
Under the terms of the agreement, Nuclea will assume responsibility for the repayment of a $2.5 million loan, and pay WILEX AG royalties on some sales.
Anda sedang membaca artikel tentang
Nuclea deal to open hospital doors
Dengan url
http://bintanggugel.blogspot.com/2013/09/nuclea-deal-to-open-hospital-doors.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Nuclea deal to open hospital doors
namun jangan lupa untuk meletakkan link
Nuclea deal to open hospital doors
sebagai sumbernya
0 komentar:
Posting Komentar